Valuation: Biogen Inc.

Market Cap 29.37B 25.69B 23.69B 21.92B 41.6B 2,803B 42.3B 284B 111B 1,377B 110B 108B 4,768B P/E 2026 *
30.3x
P/E 2027 * 16.7x
Enterprise Value 34.88B 30.51B 28.13B 26.03B 49.41B 3,329B 50.23B 337B 132B 1,635B 131B 128B 5,662B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.17x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week-7.96%
Current month-7.94%
1 month-0.10%
3 months+12.31%
6 months+6.02%
Current year+13.02%
1 week 196
Extreme 196
215.95
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
281.68
5 years 110.04
Extreme 110.035
358.77
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Chairman

2,005 0.0014%
09/06Fiscal year

Director

6,245 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-7.96%+49.53%-27.69% 29.58B
+0.76%+2.09%+20.88%-3.54% 67.44B
+0.52%-5.52%+46.80%+219.12% 53.98B
-2.79%+32.50%+32.50%+32.50% 41.77B
-1.56%+1.44%-49.03%-53.22% 41.15B
+3.74%-4.01%+133.49%-35.59% 29.28B
+1.07%+1.42%+72.47%+90.95% 23.43B
+4.46%+2.96%+12.65%+203.87% 19.11B
+1.14%-0.17%+68.83%+135.40% 16.82B
+15.12%+16.82%+96.11%+433.87% 15.36B
Average +2.20%+0.04%+48.42%+99.57% 33.79B
Weighted average by Cap. +1.04%-0.77%+39.13%+70.62%

Financials

2026 *2027 *
Net sales 10.04B 8.78B 8.1B 7.49B 14.22B 958B 14.46B 96.96B 38.01B 470B 37.68B 36.86B 1,630B 10.35B 9.05B 8.35B 7.72B 14.66B 988B 14.9B 99.95B 39.18B 485B 38.84B 38B 1,680B
Net income 1.51B 1.32B 1.22B 1.13B 2.14B 144B 2.18B 14.61B 5.73B 70.9B 5.68B 5.56B 246B 1.95B 1.7B 1.57B 1.45B 2.76B 186B 2.81B 18.82B 7.38B 91.29B 7.31B 7.15B 316B
Net Debt 5.51B 4.82B 4.44B 4.11B 7.8B 526B 7.93B 53.22B 20.86B 258B 20.68B 20.23B 894B 3.38B 2.96B 2.73B 2.53B 4.8B 323B 4.88B 32.7B 12.82B 159B 12.71B 12.43B 550B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
09/07/26 USD 198.91 -0.72% 1,657,324
08/07/26 USD 200.36 -2.60% 1,947,888
07/07/26 USD 205.70 -1.32% 1,156,880
06/07/26 USD 208.46 -3.54% 1,218,492
02/07/26 USD 216.12 +3.04% 1,155,165
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
198.91USD
Average target price
222.83USD
Spread / Average Target
+12.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock